🏛️ Verified NIH Record • Updated 2026-02-24
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases (NCT06626919)
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Arcellx, Inc.
🩺 Plain-English Summary (8th-Grade Level)
A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG). Anitocabtagene autoleucel (anito-cel) is a BCMA-directed CAR-T cell therapy.
Who can join: Review the eligibility criteria below.
Location: UCLA Medical Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- UCLA Medical Center — Los Angeles, California
- University of California, Irvine — Orange, California
- Stanford Hospital — Palo Alto, California
- University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare — Tampa, Florida
- Karmanos Cancer Institute — Detroit, Michigan
- University of Minnesota Delaware Clinical Research Unit — Minneapolis, Minnesota
- Mayo Clinic — Rochester, Minnesota
- Columbia University Irving Medical Center — New York, New York
- Ohio State University — Columbus, Ohio
- Oregon Health & Science University (OHSU) — Portland, Oregon
- Temple University Hospital — Philadelphia, Pennsylvania
- UT Southwestern Medical Center — Dallas, Texas
- Houston Methodist Hospital — Houston, Texas
📞 Contact the Study Coordinator
Phone: (240) 327-0379
Email: clinical@arcellx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Muscular Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.